Also listed on Shire LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jan 8, 2032 · Low confidence
20-year base term ends Oct 27, 2031
Held by Shire Viropharma LLC
Filed Aug 3, 2020 as application 16/983,310 · Granted Jun 27, 2023
Base term plus 73 days of patent term adjustment (USPTO delay)
Today
2011
2032
Clock starts
Oct 27, 2011
Oct 27, 2011
Term ends
Jan 8, 2032
Jan 8, 2032
Granted
Jun 27, 2023
Jun 27, 2023
base term
patent term adjustment
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
73
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,940,707, to Jan 8, 2032. The term already ends on or before that date, so the cap shortened nothing.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
12
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 73 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 2 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 27, 2011, when application 13/282,501, the earliest non-provisional in its chain, was filed (this one was filed Aug 3, 2020); a parent in its chain could not be resolved (the next row) | Oct 27, 2031 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +73 days, USPTO patent term adjustment record | Jan 8, 2032 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,940,707) | resolves to Jan 8, 2032, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 2 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 16663743, 15291639, 13282501, 13282501 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Jan 8, 2032 | Low confidence |
This family
| US 8,940,707 | In force Jun 2032 | Jun 2032 |
| Application 14/595,548 | Abandoned not computed | not computed |
| Application 15/055,043 | Abandoned not computed | not computed |
| US 10,485,813 | In force Jan 2032 | Jan 2032 |
| US 10,765,692 | In force Oct 2031 | Oct 2031 |
| US 11,684,632 | this patent Jan 2032 | Jan 2032 |
| Application 18/200,636 | Abandoned not computed | not computed |
| Application 18/594,712 | Abandoned not computed | not computed |
8 of 12 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 20, 2021 Reel 56307, frame 254 | Shire Viropharma LLC | Takeda Pharmaceutical Company Limited | Assignment of Assignor's Interest |
| Jun 15, 2021 Reel 56554, frame 90 | Peabody, John D., III | Viropharma Incorporated | Assignment of Assignor's Interest |
| Jun 15, 2021 Reel 56596, frame 362 | Viropharma Incorporated | Shire Viropharma Incorporated | Change of Name |
| Jun 15, 2021 Reel 56596, frame 380 | Shire Viropharma Incorporated | Shire Viropharma LLC | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2032
Term ends Jan 8, 2032. Maintenance fees still fall due before then
Note
The 73 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,940,707, ends no earlier than this term, so it caps nothing.
Citations
2
later US patents cite this one
That is above the median of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.